SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-031993
Filing Date
2023-09-07
Accepted
2023-09-07 17:01:43
Documents
12
Period of Report
2023-09-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 68870
  Complete submission text file 0001493152-23-031993.txt   248667

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lctx-20230906.xsd EX-101.SCH 3024
3 XBRL LABEL FILE lctx-20230906_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE lctx-20230906_pre.xml EX-101.PRE 22795
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3497
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 231242967
SIC: 2836 Biological Products, (No Diagnostic Substances)